Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPCORITAMAB vs RITUXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EPCORITAMAB vs RITUXIMAB: Safety Overview

Metric EPCORITAMAB RITUXIMAB
Total FAERS Reports 2,041 178,614
Deaths Reported 430 28,910
Death Rate 21.1% 16.2%
Hospitalizations 1,652 54,631
Average Patient Age 67.5 yrs 54.6 yrs
% Female Patients 47.5% 64.3%
Manufacturer Genmab US, Inc. Genentech, Inc.
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status N/A Prescription